Trial record 17 of 45 for:    " January 06, 2010":" February 05, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
University of Missouri-Columbia
ClinicalTrials.gov Identifier:
NCT01050465
First received: January 13, 2010
Last updated: March 1, 2011
Last verified: March 2011
  Purpose

The specific aim of this proposed pilot study is to compare two standardized processes (paper and electronic) to deliver a customized MedlinePlus health information prescription.

Primary Hypothesis. Individuals in the paper prescription group will be just as likely to seek information using MedlinePlus compared with individuals in the group who receive the same customized information through an email prescription.

Secondary Hypothesis. Individuals in the paper prescription group will be just as likely to have successful behavioral outcome measures as those in the group who receive the same customized information through an email prescription.


Condition Intervention
Acne Vulgaris
Allergic Rhinitis (Disorder)
Anxiety
Asthma
Back Pain
Prostatic Hyperplasia
Bursitis
Chronic Obstructive Pulmonary Disease
Cough
Coronary Artery Disease
Depression
Diabetes Mellitus
Diarrhea
Gastroesophageal Reflux
Fibromyalgia
Headache
HIV Infections
Hypothyroidism
Hyperlipidemia
Hypertension
Influenza
Sleep Initiation and Maintenance Disorders
Irritable Bowel Syndrome
Knee Pain
Migraine Disorders
Obesity
Obstructive Sleep Apnea
Osteoarthritis
Senile Osteoporosis
Colonoscopy
Mammography
Shoulder Pain
Sinusitis
Smoking Cessation
Tobacco Use Cessation
Menopause
Urinary Incontinence
Urinary Tract Infection
Vaccination
Vaginitis
Vertigo
Other: health information prescription

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label

Resource links provided by NLM:


Further study details as provided by University of Missouri-Columbia:

Primary Outcome Measures:
  • seeking information using MedlinePlus [ Time Frame: clicks will be tracked on the website when they occur ] [ Designated as safety issue: No ]

Estimated Enrollment: 728
Study Start Date: May 2009
Study Completion Date: December 2010
Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: email
Patients randomized to this arm will receive an email health information prescription.
Other: health information prescription
Patients randomized to the email arm will receive a health information prescription via email on a health care topic following their clinic visit. Patients randomized to the paper arm will receive a health information prescription on paper on a health care topic following their clinic visit.
Active Comparator: paper
Patients randomized to this arm will receive a paper health information prescription.
Other: health information prescription
Patients randomized to the email arm will receive a health information prescription via email on a health care topic following their clinic visit. Patients randomized to the paper arm will receive a health information prescription on paper on a health care topic following their clinic visit.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • To be included in the study population, patients must be seen by their physician for one of the 40 target health conditions.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01050465

Sponsors and Collaborators
University of Missouri-Columbia
Investigators
Principal Investigator: Robert Hodge, MD University of Missouri-Columbia
  More Information

No publications provided by University of Missouri-Columbia

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Robert Hodge, University of Missouri
ClinicalTrials.gov Identifier: NCT01050465     History of Changes
Other Study ID Numbers: HHSN276200800445P
Study First Received: January 13, 2010
Last Updated: March 1, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by University of Missouri-Columbia:
HIV

Additional relevant MeSH terms:
HIV Infections
Acquired Immunodeficiency Syndrome
Acne Vulgaris
Anxiety Disorders
Asthma
Back Pain
Prostatic Hyperplasia
Bursitis
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Depression
Depressive Disorder
Diabetes Mellitus
Diarrhea
Fibromyalgia
Myofascial Pain Syndromes
Gastroesophageal Reflux
Headache
Hyperlipidemias
Hyperplasia
Hypertension
Hypothyroidism
Influenza, Human
Sleep Initiation and Maintenance Disorders
Irritable Bowel Syndrome
Lung Diseases
Respiration Disorders
Pulmonary Disease, Chronic Obstructive
Obesity

ClinicalTrials.gov processed this record on July 22, 2014